<DOC>
	<DOCNO>NCT02092870</DOCNO>
	<brief_summary>Our study aim explore effect Adipose Derived Stem Cells ( ASCs ) chronic wound .</brief_summary>
	<brief_title>Adipose Derived Regenerative Cellular Therapy Chronic Wounds</brief_title>
	<detailed_description>In attempt explore contribution Adipose Derived Stem Cells ( ASCs ) chronic wound healing , investigate effect inject ASCs periphery debrided surface chronic wound . Our goal achieve heal two month , wound stay heal follow two week .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Female male patient age â‰¥ 18 With diagnosis diabetic chronic wound Grade 1 2 wound Wagner Scale Ulcer surface area comprise great 4 cm2 include ( mechanical debridement ulcer ) For subject one wound meet criterion , qualify wound may treat Patient 's wound refractory standard care ( measureable sign heal least 30 day ) Patient adequate ( &gt; 200cc ) abdominal subcutaneous adipose tissue accessible syringebased lipoharvest Patient activate platelet thromboplastin time ( aPTT ) &lt; 1.6x mean normal reference interval time lipoharvest procedure contraindication lipoharvest Typical Charcot 's foot Presence osteitis ( eq Br osteomyelitis ) inclusion visit ( evidenced radiological lesion face wound [ bone erosion disappearance cortical bone ] ) determine MRI Clinical evidence uncontrolled infection inclusion visit Patient eligible syringebased lipoharvest least 200cc subcutaneous adipose tissue Subjects cancerous precancerous lesion area treat Patient work activity sickleave study period Patient suffer psychiatric disorder treat Clinical evidence gangrene part affect foot Patient receiving corticosteroid , NSAIDs , immunosuppressive cytotoxic agent , systemic agent affect wound repair treatment might interfere assessment study treatment Pregnant nursing female Patient receive dialysis renal insufficiency severe renal dysfunction Patient offload method Participation clinical research study reach primary efficacy endpoint otherwise would interfere patient 's participation study Any concurrent disease condition , opinion investigator , would make patient unsuitable participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Chronic Wounds</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Adipose Derived Stem Cells</keyword>
	<keyword>Diabetic Foot</keyword>
</DOC>